We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PROPOSED MYLAN-KING MERGER BURNS ANALYSTS, INVESTORS
The pending acquisition of brand firm King Pharmaceuticals by generic heavyweight Mylan Laboratories is drawing fire from Mylan’s two largest shareholders, as well as industry analysts.